ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,525.00
-5.00 (-0.14%)
At close: Sep 23, 2026

ISU Abxis Revenue

ISU Abxis had revenue of 14.93B KRW in the quarter ending June 30, 2026, a decrease of -34.61%. This brings the company's revenue in the last twelve months to 51.04B, down -14.10% year-over-year. In the year 2025, ISU Abxis had annual revenue of 56.67B, down -5.95%.

Revenue (ttm)
51.04B
Revenue Growth
-14.10%
P/S Ratio
2.82
Revenue / Employee
286.75M
Employees
178
Market Cap
143.73B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202556.67B-3.59B-5.95%
Dec 31, 202460.26B5.95B10.96%
Dec 31, 202354.31B13.14B31.91%
Dec 31, 202241.17B13.15B46.94%
Dec 31, 202128.02B2.41B9.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Cell Biotech60.40B
Prestige Biologics26.67B
NIBEC22.60B
Bio Solution17.39B
TiumBio15.00B
curacle co.,ltd.8.24B
Y-Biologics3.17B
Kangstem Biotech3.03B
Revenue Rankings